Skip to content

Effect of Cordia Myxa,s herbal syrup on the Treatment of Dry Coughing

Comparison of Cordia Myxa,s herbal syrup and Diphenhydramine in the treatment of dry cough

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170809035599N1
Enrollment
124
Registered
2019-02-19
Start date
2018-11-11
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry cough. Cough

Interventions

Intervention 1: Intervention group: The recipients of Cordia Myxa,s herbal syrup (62 patients)Cordia Myxa,s herbal syrup produced in pharmaceutical technology incubator of Ahvaz jundishapur University

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Children aged 6-12 years who referred to the clinic with the main complaint of acute cough and without foreign body aspiration on the first or second day of coughing. The associated symptoms include upper respiratory tract infections, mild fever (oral temperature 37.8-38.3), rhinorrhea, sneezing, mild sore throat, mild headache, Mild nasal congestion, hoarse voice, conjunctivitis.

Exclusion criteria

Exclusion criteria: Symptoms of bacterial infection of the upper respiratory tract: middle to sever fever, severe sore throat with ingestion, nausea, vomiting, abdominal pain and severe headache. The presence of symptoms of lower respiratory tract infection: high fever, cough, dyspnea, boredom, chest pain and tachypnea pain. The presence of symptoms of airway reactions including wheezing, tachypnea, dyspnea. Signs of allergy such as the presence of symptoms of nose and eye itching, or a history of repetitions of similar symptoms and outer body spiration. Avoid taking medication before referral Start the symptoms of otitis or sinusitis. Start symptoms of low respiratory involvement.

Design outcomes

Primary

MeasureTime frame
Cough. Timepoint: One day before the intervention and three days after the intervention began. Method of measurement: The number and severity of patients' night and day coughing.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmanollah Zarei Ahmady

Ahvaz University of Medical Sciences

amanazarei@ymail.com+98 61 3336 1969

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026